Paper34041283
Dissecting Calcific Aortic Valve Disease-The Role, Etiology, and Drivers of Valvular Fibrosis.
Büttner P and 5 others. Front Cardiovasc Med, 2021. Cited by 39 papers, by iCite.
Cite this record
ConductScience Library. Dissecting Calcific Aortic Valve Disease-The Role, Etiology, and Drivers of Valvular Fibrosis. Papers, record 34041283. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34041283
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Dissecting Calcific Aortic Valve Disease-The Role, Etiology, and Drivers of Valvular Fibrosis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References160
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25768904 | Human disease modeling reveals integrated transcriptional and epigenetic mechanisms of NOTCH1 haploinsufficiency. | Cell | 2015 | https://conductscience.org/library/papers/25768904 | PubMed |
| 2 | 15596058 | Influence of receptor activator of nuclear factor kappa B on human aortic valve myofibroblasts. | Exp Mol Pathol | 2005 | https://conductscience.org/library/papers/15596058 | PubMed |
| 3 | 26996755 | Simulation of early calcific aortic valve disease in a 3D platform: A role for myofibroblast differentiation. | J Mol Cell Cardiol | 2016 | https://conductscience.org/library/papers/26996755 | PubMed |
| 4 | 25806913 | Forced vital capacity in idiopathic pulmonary fibrosis--FDA review of pirfenidone and nintedanib. | N Engl J Med | 2015 | https://conductscience.org/library/papers/25806913 | PubMed |
| 5 | 33532664 | Proteomic Architecture of Valvular Extracellular Matrix: FNDC1 and MXRA5 Are New Biomarkers of Aortic Stenosis. | JACC Basic Transl Sci | 2021 | https://conductscience.org/library/papers/33532664 | PubMed |
| 6 | 32168892 | Proteoglycan 4 is Increased in Human Calcified Aortic Valves and Enhances Valvular Interstitial Cell Calcification. | Cells | 2020 | https://conductscience.org/library/papers/32168892 | PubMed |
| 7 | 22940605 | 5-HT(2B) antagonism arrests non-canonical TGF-β1-induced valvular myofibroblast differentiation. | J Mol Cell Cardiol | 2012 | https://conductscience.org/library/papers/22940605 | PubMed |
| 8 | 9044068 | Aortic valve structure-function correlations: role of elastic fibers no longer a stretch of the imagination. | J Heart Valve Dis | 1997 | https://conductscience.org/library/papers/9044068 | PubMed |
| 9 | 18365571 | Mechanobiology of the aortic heart valve. | J Heart Valve Dis | 2008 | https://conductscience.org/library/papers/18365571 | PubMed |
| 10 | 19304575 | Calcification by valve interstitial cells is regulated by the stiffness of the extracellular matrix. | Arterioscler Thromb Vasc Biol | 2009 | https://conductscience.org/library/papers/19304575 | PubMed |
| 11 | 27479126 | Pathological Investigation of Congenital Bicuspid Aortic Valve Stenosis, Compared with Atherosclerotic Tricuspid Aortic Valve Stenosis and Congenital Bicuspid Aortic Valve Regurgitation. | PLoS One | 2016 | https://conductscience.org/library/papers/27479126 | PubMed |
| 12 | 15761200 | Spatial heterogeneity of endothelial phenotypes correlates with side-specific vulnerability to calcification in normal porcine aortic valves. | Circ Res | 2005 | https://conductscience.org/library/papers/15761200 | PubMed |
| 13 | 32370617 | Usefulness of Cardiac Magnetic Resonance Imaging in Aortic Stenosis. | Circ Cardiovasc Imaging | 2020 | https://conductscience.org/library/papers/32370617 | PubMed |
| 14 | 25767276 | Light to Moderate Alcohol Consumption Is Associated With Lower Risk of Aortic Valve Sclerosis: The Study of Health in Pomerania (SHIP). | Arterioscler Thromb Vasc Biol | 2015 | https://conductscience.org/library/papers/25767276 | PubMed |
| 15 | 12505585 | Progression of aortic valve sclerosis to aortic stenosis. | Am J Cardiol | 2003 | https://conductscience.org/library/papers/12505585 | PubMed |
| 16 | 11583961 | Aortic valve endothelial cells undergo transforming growth factor-beta-mediated and non-transforming growth factor-beta-mediated transdifferentiation in vitro. | Am J Pathol | 2001 | https://conductscience.org/library/papers/11583961 | PubMed |
| 17 | 31047003 | Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis. | J Am Coll Cardiol | 2019 | https://conductscience.org/library/papers/31047003 | PubMed |
| 18 | 29761409 | The Roles of Matrix Stiffness and ß-Catenin Signaling in Endothelial-to-Mesenchymal Transition of Aortic Valve Endothelial Cells. | Cardiovasc Eng Technol | 2018 | https://conductscience.org/library/papers/29761409 | PubMed |
| 19 | 15827062 | Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors. | Eur Heart J | 2005 | https://conductscience.org/library/papers/15827062 | PubMed |
| 20 | 15853603 | Bicuspid aortic valve disease: recent insights in pathophysiology and treatment. | Expert Rev Cardiovasc Ther | 2005 | https://conductscience.org/library/papers/15853603 | PubMed |
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42973842 | Immune-driven remodeling in calcific aortic valve disease: mechanisms and immunotherapeutic opportunities. | Front Immunol | 2026 | https://conductscience.org/library/papers/42973842 | PubMed |
| 42972466 | Mechanobiology in cardiac regenerative medicine: from fundamental principles to therapeutic applications. | Stem Cell Res Ther | 2026 | https://conductscience.org/library/papers/42972466 | PubMed |
| 42738837 | Inhibiting TNAP Attenuates the Aortic Valve Calcification and Reduces Oxidative Stress. | Cells | 2026 | https://conductscience.org/library/papers/42738837 | PubMed |
| 42589297 | Role of Lipoprotein(a) in Aortic Valve Calcification: Inflammatory and Oxidative Mechanisms Involved. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42589297 | PubMed |
| 42291558 | A review of the pathogenic mechanism and clinical management progress of in-stent calcification restenosis. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42291558 | PubMed |
| 42104263 | Proteomic and degradomic signatures of extracellular matrix remodeling in calcific aortic valve stenosis. | Mol Med | 2026 | https://conductscience.org/library/papers/42104263 | PubMed |
| 42004334 | Capturing Multiscale Dynamics of Aortic Valve Calcification with a Coupled Fluid-Structure and Systems Biology Model. | ACS Omega | 2026 | https://conductscience.org/library/papers/42004334 | PubMed |
| 41892332 | Calcific Aortic Valve Disease: Mechanism and Future Therapeutic Strategies. | Cells | 2026 | https://conductscience.org/library/papers/41892332 | PubMed |
| 41550125 | Global burden of non-rheumatic calcific aortic valve disease in adults aged 60 years and older, with projections to 2041: insights from the Global Burden of Disease Study 2021. | Int J Cardiol Cardiovasc Risk Prev | 2026 | https://conductscience.org/library/papers/41550125 | PubMed |
| 41310873 | Changing trends in burden of calcific aortic valve diseases and degenerative mitral valve diseases among people aged 60-89 years from 1990 to 2030. | Eur J Med Res | 2025 | https://conductscience.org/library/papers/41310873 | PubMed |
| 41281748 | Extracellular matrix dysregulation in aging, calcification, and cancer diseases: insights into cellular senescence, inflammation, and novel therapeutic strategies. | Int J Biol Sci | 2025 | https://conductscience.org/library/papers/41281748 | PubMed |
| 40745526 | Aortic valve stenosis and osteoporosis: insights from a mouse model. | BMC Cardiovasc Disord | 2025 | https://conductscience.org/library/papers/40745526 | PubMed |
| 40461477 | Sex-specific lipidomic signatures in aortic valve disease reflect differential fibro-calcific progression. | Nat Commun | 2025 | https://conductscience.org/library/papers/40461477 | PubMed |
| 40159645 | Unveiling the Angiogenic Potential and Functional Decline of Valve Interstitial Cells During Calcific Aortic Valve Stenosis Progression. | J Cell Mol Med | 2025 | https://conductscience.org/library/papers/40159645 | PubMed |
| 40028289 | A chronological history of heart valve prostheses to offer perspectives of their limitations. | Front Bioeng Biotechnol | 2025 | https://conductscience.org/library/papers/40028289 | PubMed |
| 39835393 | Non-Canonical TERT Activity Initiates Osteogenesis in Calcific Aortic Valve Disease. | Circ Res | 2025 | https://conductscience.org/library/papers/39835393 | PubMed |
| 39180097 | Oxygenator assisted dynamic microphysiological culture elucidates the impact of hypoxia on valvular interstitial cell calcification. | J Biol Eng | 2024 | https://conductscience.org/library/papers/39180097 | PubMed |
| 38504720 | Aortic valve cell microenvironment: Considerations for developing a valve-on-chip. | Biophys Rev (Melville) | 2021 | https://conductscience.org/library/papers/38504720 | PubMed |
| 38486246 | Autotaxin inhibition attenuates the aortic valve calcification by suppressing inflammation-driven fibro-calcific remodeling of valvular interstitial cells. | BMC Med | 2024 | https://conductscience.org/library/papers/38486246 | PubMed |
| 38003903 | Analysis of Prevalence and Clinical Features of Aortic Stenosis in Patients with and without Bicuspid Aortic Valve Using Machine Learning Methods. | J Pers Med | 2023 | https://conductscience.org/library/papers/38003903 | PubMed |
Genes43
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34041283
GET https://conductscience.org/api/papers/v1/34041283/references?page=2